Enzo Biochem, Inc. Gains 37.84%
Tue, Mar 16, 2021 at 05:30 PM
Enzo Biochem, Inc. (ENZ:NYSE) soared at $4.08, a gain of 37.8%. The stock appeared on our News Catalysts scanner on Tue 16 Mar 21 at 12:08 PM in the 'BIOTECH' category. From Mon 01 Mar 21, the stock recorded 60.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Enzo Biochem, Inc. (ENZ:NYSE)
Enzo Biochem Inc is engaged in research, development, manufacturing and marketing of health care products, platforms and services. The Company's business segments are Enzo Clinical Labs, Enzo Life Sciences, and Enzo Therapeutics.
Top 10 Gainers:
- SunLink Health Systems, Inc. (SSY:NYSEMKT), 151.3%
- FTCV (FTCV:NASDAQ), 43.43%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 43.14%
- Enzo Biochem, Inc. (ENZ:NYSE), 37.84%
- Lizhi Inc. (LIZI:NASDAQ), 29.51%
- New Fortress Energy LLC (NFE:NASDAQ), 27.38%
- aTyr Pharma, Inc. (LIFE:NASDAQ), 26.34%
- Capital Senior Living Corporation (CSU:NYSE), 24.81%
- CYTH (CYTH:NASDAQ), 21.91%
- J.Jill, Inc. (JILL:NYSE), 21.43%